{"id":"W4408898205","doi":"10.1016/j.esmoop.2024.104014","title":"OP02-5 Three-year survival and safety analysis from the Phase 3 TOPAZ-1 study of durvalumab plus chemotherapy in biliary tract cancer with Korean subset","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Biliary tract cancer; Chemotherapy; Biliary tract; Topaz; Internal medicine; Medicine; Oncology; Cancer; Chemistry; Gemcitabine; Mineralogy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003065997,0.0008532318,0.001591633,0.0004438133,0.0003213909,0.001126617,0.0006982164,0.0005038118,0.002202659],"category_scores_gemma":[0.001645837,0.0003713881,0.003823915,0.0007209008,0.000384959,0.0008526439,0.0005564672,0.001792184,0.0003044716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009358413,"about_ca_system_score_gemma":0.001335421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001532733,"about_ca_topic_score_gemma":0.004765852,"domain_scores_codex":[0.99902,0.0004556468,0.00008295073,0.0001349651,0.0001268687,0.0001795519],"domain_scores_gemma":[0.9988694,0.0002763021,0.0003385692,0.0001771696,0.0001022744,0.000236301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6910225,0.00485181,0.1526613,0.002481688,0.03665004,0.0003386381,0.0002685795,0.003762025,0.01130245,0.0006079817,0.008680151,0.08737289],"study_design_scores_gemma":[0.2465449,0.1307246,0.5388914,0.0003196386,0.05359169,0.001010574,0.0004459765,0.003704449,0.006377125,0.0009513784,0.01729397,0.0001442229],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880157,0.00523984,0.0004595755,0.0002357311,0.00007226552,0.0003591869,0.004063308,0.0000354258,0.001518846],"genre_scores_gemma":[0.9870139,0.001868775,0.0004311088,0.0005207652,0.00006823985,0.0003680571,0.008738508,0.00002813906,0.0009625689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003065997,"threshold_uncertainty_score":0.01621479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03025737984054942,"score_gpt":0.3417560505693193,"score_spread":0.3114986707287699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}